Wensu Wei - State Key Laboratory of Oncology in South China; Collaborative Innovation Cencer for Cancer Medicine, Sun Yat-Sen University Cancer Center

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 45 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Significance of Immune Evasion-Related Genes in Clear Cell Renal Cell Carcinoma Immunotherapy

Tingxuan Huang,Yulu Peng,Ruiqi Liu,Binglei Ma, Junlin Chen,Wensu Wei,Weifeng Zhong,Yang Liu,Shengjie Guo,Hui Han,Fangjian Zhou, Zhiling Zhang, Liru He,Pei Dong

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

引用0浏览0WOS引用

Efficacy and Safety of First-Line TKI Plus ICI Therapy in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Multiple-Centre Study

Xi Zhong,Tingxuan Huang,Yulu Peng, Cheoklong Ng, Xuhao Liu,Taile Jing,Wensu Wei, Zhiling Zhang,Hui Han,Minfeng Chen,Liru He,Jiwei Huang,Pei Dong

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Real-world Outcomes among Patients with Advanced/metastatic Renal Cell Carcinoma (mrcc) Treated with Tyrosine Kinase Inhibitors (tkls) Monotherapy or TKI-IO Combination Therapy

Pei Dong,Tingxuan Huang,Yulu Peng,Wensu Wei,Lijuan Jiang, Xi Zhong,Zhiling Zhang,Hui Han,Fangjian Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study

Tingxuan Huang,Jun Wang,Ruiqi Liu,Wensu Wei,Yang Liu,Zhiling Zhang,Shengjie Guo,Hui Han,Fangjian Zhou,Liru He,Pei Dong

CLINICAL GENITOURINARY CANCERno. 2 (2024)

引用0浏览0WOS引用

Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway (vol 108, pg 2166, 2017)

Gang-jun Yuan,Xin Chen,Jun Lu,Zi-hao Feng,Si-liang Chen,Ri-xin Chen,Wen-su Wei,Fang-jian Zhou,Dan Xie

CANCER SCIENCEno. 4 (2023): 1771-1771

引用0浏览0引用

An Exploratory Prospective Clinical Study on Efficacy and Safety of Anlotinib Combined with Sintilimab As First-Line Treatment in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

Pei Dong,Wensu Wei,Lijuan Jiang,Zhiling Zhang, Deling Wang, Yulu Peng, Tingxuan Huang, Xi Zhong,Shengjie Guo,Hui Han,Xiuyu Cai,Fangjian Zhou

European Urology (2023): S753-S753

引用0浏览0引用

Supplementary Data from Genomic Characteristics and Single-Cell Profiles after Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma

Pei Dong,Xinyue Zhang,Yulu Peng,Yijun Zhang,Ruiqi Liu,Yilin Li, Qiwen Pan,Wensu Wei,Shengjie Guo, Zhiling Zhang,Hui Han,Fangjian Zhou,Yang Liu, Liru He

openalex（2023）

引用0浏览0引用

Preliminary Results from a Phase II Study Comparing Sunitinib Alone or with Stereotactic Body Radiotherapy (SBRT) for Newly Diagnosed Oligometastatic Renal Cell Carcinoma

Yang Liu,Wensu Wei,Zhiling Zhang,Ruiqi Liu, Jianming Gao,Shengjie Guo,Hui Han,Pei Dong,Liru He,Fangjian Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

M5c-Dependent Cross-Regulation Between Nuclear Reader ALYREF and Writer NSUN2 Promotes Urothelial Bladder Cancer Malignancy Through Facilitating RABL6/TK1 Mrnas Splicing and Stabilization

Ning Wang,Ri-xin Chen,Min-hua Deng,Wen-su Wei,Zhao-hui Zhou,Kang Ning,Yong-hong Li,Xiang-dong Li,Yun-lin Ye,Jun-hua Wen,Biao Dong,Xue-pei Zhang,Zhuo-wei Liu,Fang-jian Zhou

Cell death and disease（2023）

引用1浏览0WOSNATURE引用

转移性延胡索酸水合酶缺陷型肾细胞癌一线靶免联合疗效分析

陈俊儒, 赵俊杰,徐云泽,孔文,危文素,何立儒,周芳坚, 薛蔚, 魏强, 董培, 张进, 曾浩

Chinese Journal of Urologyno. 6 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn